Immunotoxins that Target an Oncogenic Mutant Epidermal Growth Factor Receptor Expressed in Human Tumors

Clinical Cancer Research

Volumn 1, Issue 8, 1995, Pages 859-864

  Wikstrand, Carol J ^b   Batra, Surinder K ^b   Signer, Darell D ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOTOXIN; MONOCLONAL ANTIBODY; PSEUDOMONAS EXOTOXIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FIBROBLAST; MOUSE; MUTANT; NONHUMAN; ONCOGENE; PRIORITY JOURNAL;

3T3 CELLS; ANIMAL; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CELL SURVIVAL; DRUG DESIGN; FEMALE; GLIOMA; HUMAN; IMMUNOTOXINS; LUNG NEOPLASMS; MICE; MUTAGENESIS, SITE-DIRECTED; OLIGOPEPTIDES; PROTEIN SORTING SIGNALS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEINS; SEQUENCE DELETION; TRANSFECTION;

EID: 0029057002     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Pai, L. H., and Pastan, I. Immunotoxins and recombinant toxins for cancer treatment. In: V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Important Advances in Oncology, pp. 3–19. Philadelphia: J. B. Lippincott Company, 1994.
2. Pastan, I., Chaudhary, V., and FitzGerald, D. J. Recombinant toxins as novel therapeutic agents. Annu. Rev. Biochem., 61: 331–354, 1992.
3. Allured, V. S., Collier, R. J., Carroll, S. F., and McKay, D. B. Structure of exotoxin A of Pseudomonas aeruginosa at 3.0 Angstrom. Proc. Natl. Acad. Sci. USA, 83: 1320–1324, 1986.
4. Kounnas, M. Z., Morris, R. E., Thompson, M. R., FitzGerald, D. J., Strickland, D. K., and Saelinger, C. B. The α2-macroglobulin receptor/ low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J. Biol. Chem., 267: 12420–12423, 1992.
5. Humphrey, P. A., Wong, A. J., Vogelstein, B., Zalutsky, M. R., Fuller, G. N., Archer, G. E., Friedman, H. S., Kwatra, M. M., Bigner, H., and Bigner, D. D. Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc. Natl. Acad. Sci. USA, 87: 4207–4211, 1990.
6. Sugawa, N., Ekstrand, A. J., James, C. D., and Collins, V. P. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc. Natl. Acad. Sci. USA, 87: 8602–8606, 1990.
7. Wong, A. J., Ruppert, J. M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. S., and Vogelstein, B. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl. Acad. Sci. USA, 89: 2965–2969, 1992.
8. Garcia de Palazzo, I. E., Adams, G. P., Sundareshan, P., Wong, A. J., Testa, J. R., Bigner, D. D., and Weiner, L. M. Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. Cancer Res., 53: 3217–3220, 1993.
9. Yamazaki, H., Ohba, Y., Tamaoki, N., and Shibuya, M. A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors. Jpn. J. Cancer Res., 81: 773–779, 1990.
10. Ekstrand, J. A., Longo, N., Hamid, M. L., Olson, J. J., Liu, L., Collins, V. P., and James, C. D. Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene, 9: 2313–2320, 1994.
11. Nishikawa, R., Ji, X.-D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavanee, W. K., and Huang, H.-J.S. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl. Acad. Sci. USA, 91: 7727–7731, 1994.
12. Lax, I., Burgess, W. H., Bellot, F., Ullrich, A., Schlessinger, J., and Givol, D. Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling. Mol. Cell. Biol., 8: 1831–1834, 1988.
13. Pruss, R. M., and Herschman, H. R. Variants of 3T3 cells lacking mitogenic response to epidermal growth factor. Proc. Natl. Acad. Sci. USA, 74: 3918–3921, 1977.
14. Pastan, I., Lovelace, E. T., Gallo, M. G., Rutherford, A. V., Magnani, J. L., and Willingham, M. C. Characterization of monoclonal antibodies B1 and B3 that react with mucinous adenocarcinomas. Cancer Res., 51: 3781–3787, 1991.
15. Theuer, C. P., Kreitman, R. J., FitzGerald, D. J., and Pastan, I. Immunotoxins made with a recombinant form of Pseudomonas exotoxin A that do not require proteolysis for activity. Cancer Res., 53: 340–347, 1993.
16. Collier, R. J., and Kandel, J. Structure and activity of diphtheria toxin. I. Thiol dependent dissociation of a fraction of toxin into enzymatically active and inactive fragments. J. Biol. Chem., 246: 1496–1503, 1971.
17. Prior, T. I., FitzGerald, D. J., and Pastan, I. Barnase toxin: a new chimeric toxin composed of pseudomonas exotoxin A and bamase. Cell, 64: 1017–1023, 1991.
18. Ogata, M., Fryling, C. M., Pastan, I., and FitzGerald, D. J. Cell-mediated cleavage of Pseudomonas exotoxin between Arg279 and Gly280 generates the enzymatically active fragment which translocates to the cytosol. J. Biol. Chem., 267: 25396–25401, 1992.
19. Seetharam, S., Chaudhary, V. K., FitzGerald, D., and Pastan, I. Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL. J. Biol. Chem., 266: 17376–17381, 1991.
20. Bigner, S. H., Humphrey, P. A., Wong, A. J., Vogelstein, B., Mark, J., Friedman, H. S., and Bigner, D. D. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res., 50: 8017–8022, 1990.
21. Pai, L. H., Gallo, M. G., FitzGerald, D. J., and Pastan, I. Antitumor activity of a transforming growth factor α-Pseudomonas exotoxin fusion protein (TGF-α-PE40). Cancer Res., 51: 2808–2812, 1991.
22. Theuer, C. P., FitzGerald, D., and Pastan, I. A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing. J. Biol. Chem., 267: 16872–16877, 1992.
23. Brinkmann, U., Pai, L. H., FitzGerald, D. J., Willingham, M., and Pastan, I. B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice. Proc. Natl. Acad. Sci. USA, 88: 8616–8620, 1991.
24. Chaudhary, V. K., Queen, C., Junghans, R. P., Waldmann, T. A., FitzGerald, D. J., and Pastan, I. A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature (Lond.), 339: 394–397, 1989.
25. Reiter, Y., Brinkmann, U., Webber, K., Jung, S-H., Lee, B., and Pastan, I. Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv. Protein Eng., 7: 697–704, 1994.
26. Yokota, T., Milenic, D. E., Withlow, M., and Schlom, J. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res., 52: 3402–3408, 1992.
27. Ullrich, A., and Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell, 61: 203–212, 1990.
28. Felder, S., Miller, K., Moehren, G., Ullrich, A., Schlessinger, J., and Hopkins, C. R. Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body. Cell, 61: 623–634, 1990.
29. Glenney, J. R. J., Chen, W. S., Lazar, C. S., Walton, G. M., Zokas, L. M., Rosenfeld, M. G., and Gill, G. N. Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies. Cell, 52: 675–684, 1988.
30. Kwatra, M. M., Bigner, D. D., and Cohn, J. A. The ligand binding domain of the epidermal growth factor receptor is not required for receptor internalization. Biochim. Biophys. Acta, 1134: 178–181, 1992.